VCP
BIIB icon

Verus Capital Partners’s Biogen BIIB Stock Holding History

Verus Capital Partners’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$73K Sell
230
-95
-29% -$28.8K 0.02% 387
2019
Q4 		$96K Buy
+325
New +$90.2K 0.03% 395

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Verus Capital Partners's BIIB Position: Q1 2020 in Review

Verus Capital Partners reduced its Biogen (BIIB) stake by 29% in Q1 2020, selling an estimated $28.8K and leaving 230 shares worth $73K. The position accounts for 0.02% of the portfolio, ranked #387.

Verus Capital Partners first reported a position in BIIB in Q4 2019 and has held it in 2 quarters since. The position peaked at $96K in Q4 2019. 1,098 funds tracked by Wall St. Rank hold BIIB as of Q1 2020.

  • Verus Capital Partners held 230 shares of Biogen worth $73K as of Q1 2020.
  • Verus Capital Partners sold 95 Biogen shares in Q1 2020, an estimated $28.8K.
  • Biogen made up 0.02% of Verus Capital Partners's portfolio in Q1 2020, its #387 holding.
  • Verus Capital Partners first reported a position in Biogen in Q4 2019 and has held it in 2 quarters since.
  • Verus Capital Partners's Biogen position peaked at $96K in Q4 2019.
  • 1,098 funds tracked by Wall St. Rank held Biogen as of Q1 2020.

Based on Verus Capital Partners's 13F filing for Q1 2020, filed 26 May 2020.